Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Cardiovasc Toxicol. 2020 Oct 12;21(2):169–178. doi: 10.1007/s12012-020-09610-5

Table 1:

Baseline characteristics

All patients Current smoker
N=136 Yes (N=53, 39%) No (N=83, 61%) p value
Age (years)* 52, 10 53, 10 50, 9 0.05
BMI (kg/m2)* 33, 8 34, 8 31, 7 0.06
SBP (mm Hg)* 133, 23 132, 22 136, 24 0.15
DBP (mm Hg)* 81, 13 80, 11 81, 16 0.37
Heart rate (beats/min)* 73, 15 74, 15 73, 15 0.99
Male gender 72, 53% 43, 52% 30, 57% 0.58
Caucasian 77, 57% 46, 55% 31, 59% 0.73
Hypertension 118, 87% 74, 89% 45, 85% 0.47
Prior MI 62, 46% 40, 48% 23, 43% 0.58
Diabetes 43, 32% 28, 34% 15, 28% 0.51
Stroke 23, 17% 14, 17% 10, 19% 0.77
Arrhythmia 45, 33% 28, 34% 17, 32% 0.84
Beta blocker 98, 73% 65, 78% 34, 64% 0.07
CCB 32, 24% 24, 29% 8, 15% 0.06
ACEI or ARB 89, 66% 54, 65% 35, 66% 0.91
Statin 84, 62% 55, 66% 30, 57% 0.26
Aspirin 81, 60% 49, 59% 33, 62% 0.71
Diuretics 58, 43% 38, 46% 20, 38% 0.35

Abbreviations: BMI - Body mass index, SBP- Systolic Blood Pressure, DBP – Diastolic Blood Pressure, MI – Myocardial Infarction, CCB – Calcium Channel Blocker, ACEI - Angiotensin-Converting Enzyme Inhibitor, ARB - Angiotensin II Receptor Blocker

For each variable counts and column percentage has been reported except for where indicated

*

where the mean and standard deviation (SD) are reported